Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.230
-0.030 (-2.38%)
Pre-market: Apr 29, 2026, 6:52 AM EDT
Dermata Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -7.56 | -12.29 | -7.79 | -9.61 | -7.9 | |
| Other Amortization | - | - | - | - | 0.01 | |
| Stock-Based Compensation | 0.14 | 0.66 | 0.52 | 0.93 | 1.91 | |
| Change in Accounts Payable | -0.39 | -0.11 | 0.37 | -0.02 | 0.41 | |
| Change in Other Net Operating Assets | 0.05 | 0.58 | 0.49 | -0.14 | -0.12 | |
| Operating Cash Flow | -7.76 | -11.16 | -6.41 | -8.83 | -5.69 | |
| Short-Term Debt Issued | - | - | - | - | 1.56 | |
| Total Debt Issued | - | - | - | - | 1.56 | |
| Long-Term Debt Repaid | - | - | - | - | -0.56 | |
| Net Debt Issued (Repaid) | - | - | - | - | 1.01 | |
| Issuance of Common Stock | 12.17 | 6.89 | 7.61 | 4.28 | 15.39 | |
| Repurchase of Common Stock | -0 | -0 | -0 | - | - | |
| Other Financing Activities | -0.05 | - | - | - | - | |
| Financing Cash Flow | 12.12 | 6.89 | 7.61 | 4.28 | 15.96 | |
| Net Cash Flow | 4.36 | -4.28 | 1.2 | -4.56 | 10.27 | |
| Cash Interest Paid | - | - | - | - | 0 | |
| Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | |
| Levered Free Cash Flow | -5.02 | -6.65 | -3.64 | -5.59 | -2.49 | |
| Unlevered Free Cash Flow | -5.02 | -6.65 | -3.64 | -5.59 | -2.48 | |
| Change in Working Capital | -0.34 | 0.47 | 0.86 | -0.15 | 0.29 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.